Hypertension Trial, Recruiting NCT07555574 Sponsor: Center for Eye Research Australia Condition: Hypertension
Back to Hypertension

Hypertension Trial, Recruiting

NCT07555574
Recruiting Not Applicable 🇦🇺 Australian site

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults aged 18 years or older
  • People who are able to give their informed consent to participate
  • People who are willing and able to attend a study visit at the Centre for Eye Research Australia
  • People who have been diagnosed with a retinal or optic nerve disease, such as diabetic retinopathy, glaucoma, or age-related macular degeneration
  • Healthy people without any known retinal or optic nerve disease, who are matched by age and sex to participants with a diagnosed condition

Who may not be able to join:

  • People who are unable to give informed consent
  • People with eye conditions that would prevent clear retinal imaging, such as a dense cataract, significant cloudiness of the cornea, or bleeding inside the eye
  • People with a known medical reason why eye drops used to widen the pupil would not be safe for them
  • People with a history of a narrow drainage angle in the eye, or who are considered at risk of a type of glaucoma that could be triggered by pupil dilation
  • People with any other condition that the trial investigator believes could affect their safety or the quality of the images taken

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +61 3 9959 0102

Australian sites

The Centre for Eye Research Australia, Melbourne, Victoria
+61 3 9959 0102

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Center for Eye Research Australia
Registry
ClinicalTrials.gov
Start date
1 January 2025
Est. completion
30 December 2028

Where this trial is recruiting

🇦🇺 Australia

1 site(s) in Australia. Confirm current status and contact details directly with the trial site.

Primary endpoints

Diagnostic performance of hyperspectral imaging-derived spectral score for detection of retinal disease

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov